COA page
PRODUCTS COA
Retatrutide (10mg)
Third-party analytical testing for Retatrutide 10mg (Batch R10-826 / KARI-20260901-B9WT) conducted on September 12, 2026, confirming 99.97% chromatographic purity and full specification compliance.
Tirzepatide 10mg
Third-party analytical testing for Tirzepatide 10mg (Lot T10-T120 / Accession 2602270058) conducted on February 28, 2026, confirming 99.43% analytical purity and full specification compliance.
